TRANSCRIPTOMIC AND PROTEOMIC ANALYSES OF DIPG RESPONSE TO ONC201

被引：0
|
作者：
Sridharan, Sreepradha [1 ]
Harmanci, Arif [2 ]
Sharma, Ajay [1 ]
Lai, Yanlai [1 ]
Kennis, Bridget [1 ]
Dobson, Tara [1 ]
Swaminathan, Jyothishmathi [1 ]
Haltom, Amanda [1 ]
Khatua, Soumen [1 ]
Tarapore, Rohinton [3 ]
Allen, Joshua [3 ]
Cheng, Donghang [1 ]
Zaky, Wafik [1 ]
Gopalakrishnan, Vidya [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Div Pediat, Houston, TX 77030 USA
[2] Univ Texas Hlth Sci Ctr Houston, Ctr Precis Hlth, Houston, TX 77030 USA
[3] Oncoceutics Inc, Philadelphia, PA USA
来源：
NEURO-ONCOLOGY | 2020年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
DIPG-57
引用
收藏
页码：298 / 298
页数：1
相关论文
共 50 条
  • [41] Predictive biomarker evaluation for the anti-cancer imipridone ONC201
    Morrow, Sara
    Prabhu, Varun Vijay
    Allen, Joshua E.
    Oster, Wolfgang
    CANCER RESEARCH, 2020, 80 (16)
  • [42] Impact of hypoxia on the integrated stress response activated by imipridones ONC201 and ONC206 in pediatric diffuse midline glioma cells
    Roady, Tyler J.
    Stubbs, Nolan
    Chen, Josephine
    Xia, Yutong
    Uruchurtu, Ashley Sanchez Sevilla
    Tian, Xiaobing
    Zhou, Lanlan
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2024, 84 (06)
  • [43] ONC201 kills breast cancer cells by inhibiting mitochondrial respiration
    Greer, Y. E.
    Gilbert, S. F.
    Islam, C.
    Ji, Y.
    Gattinoni, L.
    Stuelten, C.
    Voeller, D.
    Lipkowitz, S.
    CANCER RESEARCH, 2017, 77
  • [44] ONC201 kills breast cancer cells by inhibiting mitochondrial respiration
    Greer, Yoshimi
    Gilbert, Samuel
    Islam, Celia
    Ji, Yun
    Gattinoni, Luca
    Stuelten, Christina
    Porat-Shliom, Natalie
    Weigert, Roberto
    Wang, Xiantao
    Hafner, Markus
    Nagashima, Kunio
    Voeller, Donna
    Lipkowitz, Stanley
    CANCER RESEARCH, 2017, 77
  • [45] Combination of paxalisib and ONC201 for the treatment of diffuse intrinsic pontine glioma
    Jackson, Evangeline
    Duchatel, Ryan
    Mannan, Abdul
    Yadavilli, Sridevi
    Persson, Mika
    Kearney, Padraic
    Parackal, Sarah
    Douglas, Alicia
    Skerrett-Byrne, David
    Hulleman, Esther
    Carcaboso, Angel
    Monje, Michelle
    McCowage, Geoff
    Alvaro, Frank
    Waszak, Sebastian
    Larsen, Martin
    Nazarian, Javad
    Cain, Jason
    Koschmann, Carl
    Mueller, Sabine
    Dun, Matthew
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 56 - 56
  • [46] Biological activity of weekly ONC201 in adult recurrent glioblastoma patients
    Arrillaga-Romany, Isabel
    Odia, Yazmin
    Prabhu, Varun V.
    Tarapore, Rohinton S.
    Merdinger, Krystal
    Stogniew, Martin
    Oster, Wolfgang
    Allen, Joshua E.
    Mehta, Minesh
    Batchelor, Tracy T.
    Wen, Patrick Y.
    NEURO-ONCOLOGY, 2020, 22 (01) : 94 - 102
  • [47] PHASE I CLINICAL TRIAL OF ONC201 IN PEDIATRIC H3 K27M-MUTANT GLIOMA OR NEWLY DIAGNOSED DIPG
    Gardner, Sharon
    Tarapore, Rohinton
    Allen, Jeffrey
    Zaky, Wafik
    Odia, Yazmin
    Hall, Matthew
    Daghistani, Doured
    Khatib, Ziad
    Koschmann, Carl
    Aguilera, Dolly
    MacDonald, Tobey
    Fouladi, Maryam
    McGovern, Susan
    Merdinger, Krystal
    Oster, Wolfgang
    Allen, Joshua
    Khatua, Soumen
    NEURO-ONCOLOGY, 2019, 21 : 185 - 185
  • [48] ClpP drives efficacy and mediates acquired resistance with imipridones ONC201 and ONC206 in glioma in vitro
    Maranto, Cristina
    Foster, Scott
    Lee, Andrew
    Sethna, Phiroze
    Allen, Joshua E.
    Prabhu, Varun V.
    CANCER RESEARCH, 2024, 84 (05)
  • [49] TREATMENT OF A PEDIATRIC PATIENT WITH AN H3.3 K27M MUTANT DIPG WITH ONC201, A SELECTIVE DRD2 ANTAGONIST
    Suarez, Fernando
    Stafford, James M.
    Tarapore, Rohinton
    Oster, Wolfgang
    Allen, Joshua E.
    Chi, Andrew S.
    Gardner, Sharon
    NEURO-ONCOLOGY, 2018, 20 : 60 - 60
  • [50] In vitro Efficacy of the Dopamine Receptor D2 (DRD2) Antagonist ONC201, for the Treatment of Diffuse Intrinsic Pontine Glioma (DIPG)
    Jackson, Evangeline R.
    Duchatel, Ryan J.
    Dun, Andmatthew D.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 31 - 31
12345